News

   Daily Updated Pharma-News regarding R&D, FDA, F&D, Pharmaceuticals industries, Hospital Pharmacy and Pharmaceutical Development...

• Pharmacy Council of India has not approved of 2nd Shift courses in colleges
• Inform All: FDA Warns Consumers to Avoid TimeOut Capsules
• Study: Presence of murine leukemia virus related gene sequences found in CFS patients

• More cases of supplying substandard drugs to CGHS come out
• Direct Relationship Seen Between Plasma Amyloid Levels and Cognitive Decline

• Gentamicin Surgical Sponge Ineffective in Decreasing Infection Rate
• US FDA accepts NDA for Gadovist injection in magnetic resonance imaging
• Deep Brain Stimulation Shows Promise for Early Alzheimer's Disease
• Study finds Hepatitis B linked to Lymphoma
• Merck's Boceprevir scores high in Phase-III hepatitis C trial

• More Damning Evidence Against GSK and FDA on Rosiglitazone
• Stem cell therapy can help tame cancer to manageable levels
• Alzheimer's Association to launch new 'research center' website

• India is becoming big pharma's favorite hub
• Natalizumab Improves Language Processing in Patients With Multiple Sclerosis
• IPC to add monographs of radiopharmaceuticals in Indian Pharmacopoeia soon

• FDA Clears Liquid-Cooled Fiber for Benign Prostatic Hyperplasia
• Oral Nicorandil Greatly Lowers Risk for Death in Hemodialysis Patients

• Leucine-rich, glioma-inactivated 1{LGI1} Identified as Autoantigen Associated With Limbic Encephalitis
• Indian regulator GEAC approves 17 Bt crops for trials
• FICCI, DOP to organize National Convention on Biopharma in India
• Bhopal Memorial Hospital turns hot spot for clinical trials on untested drugs by MNCs

• Atorvastatin Beats Rosuvastatin in Protecting Kidneys in Diabetic and Nondiabetic Patients
• Study says normal adult blood can generate pluripotent stem cells
• Intercell vaccine patch fails Phase II trial
• Roche's new DNA sequencer opens innovation in genomic research

• The 62nd Indian Pharmaceutical Congress will be held in Manipal
• ICMR to launch task force projects on burden of rotavirus diarrhoea in India
• Karnataka pharma majors bullish over European export prospects
• New standard care of Advanced Melanoma presented in ASCO 2010 annual meeting

• Zilver Peripheral Stent Proves Durable
• US FDA to review once-weekly treatment for type 2 diabetes Bydureon in October
• AIDS Control Dept fails to achieve physical target even after utilising 98 % of allocation

• Long-Term Use of Anabolic Steroids Associated With Reduced LV Ejection Fraction
• ICRI ties up with South Carolina Medical University to offer masters in Health Administration-Global
• Deep Brain Stimulation Improves Quality of Life in Advanced Parkinson's
• GSK gets clean chit from DCGI for running cervical cancer vaccine ads in media

• HPV Testing May Detect More Precancerous Cells Than Conventional Cytology
• PCI warns pharmacy colleges planning to launch 2nd shift for B Pharm
• Cytomegalovirus Resistance Linked to Subtherapeutic Ganciclovir
• India participates in ICGC with oral cancer as site for research

• Glenmark's oral contraceptive gets FDA nod
• Manipal Hospital introduces Single Incision Laparoscopic on kidney donor
• Work for vaccine production started in 2 PSUs, BCG Lab in Chennai yet to get green signal
• State FDA lists 44 drug samples as not-of-standard drugs in March

• FDA Launches Campaign to Improve Infusion-Pump Safety
• Liraglutide Superior to Sitagliptin When Added to Metformin for Glycemic Control
• Indian pharma companies will become product companies, Reinhard Gluck, Cadila, India
• AIIMS to conduct conference on care of children born with cleft lip, palate & craniofacial anomalies

• Pharmexcil urges PM to extend sunset clause till March 2015 for pharma SEZs
• FDA warning to Propylthiouracil
• 3G technology to revolutionize Indian healthcare space
• IPA to conduct panel discussion on: how to handle expired drugs, next month

• Chennai hosts IIFT seminar to boost export potential of Ayush products
• CDC Report Confirms Pregnant Women at Increased Risk for H1N1 Death
• Institute for Ageing of New Castle university identifies molecular pathway that reacts to cell damage
• Early vs Late Tracheotomy May Not Lower Ventilator-Associated Pneumonia Risk
• Celgene forms strategic collaboration with Agios to advance unique science of cancer metabolism

• Ayush exports record remarkable growth in 10th five year Plan
• Western Ghats Task Force Board increases more Medicinal Plants Conservation Areas in Karnataka
• FDA Announces Phase Out of CFC-Based Asthma and COPD Inhalers
• India ranks 67th among developing countries in doctor-population ratios
• Experimental immune system drug worsens TB in mice

• Assam, Rajasthan & Tamil Nadu get awards for best implementation of NRHM
• Kylin Therapeutics' pRNAi technology gets US patent
• Study shows vitamin C & E supplements do not reduce risk for BP disorders in pregnancy
• NIPER to induct more scientists to help SME industry through SMPIC

• DBT looks for pharma firms to commercialise cholera vaccine
• Worlds poor to get pneumonia vaccines at affordable cost
• Karnataka govt establishes 30 Special Courts to expedite spurious drug cases
• Allergan, Serenity Pharma enter global pact for the treatment of nocturia
• LCT gets approval to advance to phase-II human trial with Diabecell
• CPhI China to be held in Shanghai from June 2 to 4

• Resistance Can Develop Fast With Swine Flu
• GSKs CAT to help COPD patients better manage their chronic lung disease
• Narayana Hrudayalaya Tissue Bank & Stem Cell Research Centre to invest Rs 1.50 cr for expansion
• PCI to meet health ministry seeking amendment in Pharmacy Act, 1948

• Centre approves establishment of Indo-German Science & Technology Centre in India
• US president Obama signs Indian Health Care Improvement Act

• Poniard Pharma suspends efforts to obtain regulatory approval for picoplatin in SCLC
• TN govt to enforce D&C Act, Rules strictly in state: Health secretary
• Antithrombotic Therapy Does Not Improve Outcomes in Recurrent Miscarriage

• PCI clarifies its notification on MS not specific on NIPER's course
• Third national IPA Convention to be held in Indore in April, 2011
• NIH creates new genetic testing registry to help researchers, consumers & healthcare providers
• Two-day 'CLINICON 2010' to be held in Bangalore from March 26

• Syngene, Endo Pharmaceuticals in oncology deal
• Deaths during clinical trials on rise as India turning as hot destination
• Piramal Healthcare acquires i-pill brand from Cipla
• Women With MI Less Likely to Get Cath Procedures

• FDA Temporarily Suspends Use of Rotarix Vaccine
• Recession hit West storms into India for clinical research, pharmacovigilance next growth path for CROs
• Drug-resistant tuberculosis now at record levels: WHO report

• Intas Pharma to introduce world’s first Interferon Lozenges in tablet form for flu in India
• Drugs of Crores Rs. seized by Tamil nadu drug authorities
• ASHP to provide free professional training to Indian pharmacists in US hospitals
• Local players to continue domination in anti-fungal drug market in India: F&S
• FDA Warning: High-Dose Simvastatin Associated With Increased Risk for Myopathy

• Bangalore India Bio expects wide biotech industry participation
• NIPER Ahmedabad to introduce PG diploma course for medical devices sector in July, 2010
• IPA demands amendment of D&C Act, separate University for pharmacy in TN

• GVK Bio opens new clinical pharmacology unit in Ahmedabad
• Several drugs to come under regulatory scanner as national pharmacovigilance programme to begin in April
• Janssen-Cilag begins marketing of Priligy in New Zealand to treat premature ejaculation
• Duty of regulatory agencies must be to prevent harm from unsafe drugs, Kim Huynh-Ba.
• NEWS: Warfarin Genotyping Reduces Hospitalizations

• Gujarat FDCA appoints 156 staff in one go to avoid backlog in samples testing
• Himalaya enters chronic respiratory allergy segment with Bresol
• Haffkine Institute to establish BA/BE study centre soon
• FDA Approves New Somatropin Injection Pen for Growth Hormone Disorders

• MakroCare to organise Webinar on Late Phase (PMS & IIT) on March 5
• US FDA approves velaglucerase alfa for injection to treat rare genetic disorder Gaucher disease
• INTERPHEX Asia to be held in Singapore on June 7
• Govt to constitute National Apex Committee for monitoring stem cell research soon
• DoP calls meeting on March 2 to discuss MS Pharmacy issue

• Gujarat drug manufacturers resort to novel method to urge govt not to hike excise duty
• Health Ministry begins process for upgradation of Clinical Trial Registry of India
• BCG Lab in Chennai will be revived with other two vaccine units: director ,health ministry
• Drug Shows Promise Against River Blindness
• India says "No" to Bt brinjal for now

• Bayer begins phase-I study with Idiotype vaccination, a personalized vaccine from tobacco plants to treat non-Hodgkin's lymphoma
• Bombay HC restrains Cipla from using Valcept trade mark for its anti viral drug valganciclovir
• FDA Approves New Lidocaine-Containing Dermal Filler Formulation
• Olanzapine Label for Adolescent Indication Changed

• Researchers discover new genes that account for new forms of osteogenesis imperfecta
• Living Cell Technologies gets European patent for neurological disease product NTCELL
• Intensive Insulin Therapy May Not Improve Survival in Septic Shock
• Study shows IMUC's lead investigational cancer vaccine ICT-107 targets cancer stem cells

• Mother Teresa Institute in Pondicherry to introduce diploma courses in pharmacy & nursing in Ayurveda
• Karnataka drugs control department issues 291 show cause notices to sales units
• Illumina launches HySeq 2000
• FDA Approves Dalfampridine to Improve Walking in Multiple Sclerosis
• Early Beta-Blockade for ACS Does Not Alter Short-Term Mortality
• Amarin Corporation Announces First Patients Enrolled In Two Phase 3 Clinical Trials Assessing AMR101 for the Treatment of Cardiovascular Disease

• India, other countries raise 'false pandemic' issue at WHO board meeting
• DBT collaborates with Germany for research projects in biotechnology
• Data from Ecole polytechnique federale de Lausanne advance knowledge in gene therapy
• 23 new drug inspectors appointed in Tamil Nadu
• ICMR to support project to develop vaccine to prevent bacterial infection in ICU patients

• Dr Reddy's suffer net loss of Rs 522 cr in Q3
• FDA clears Lupin's Mandideep drug plant
• Wockhardt Foundation joins hands with Sanjay Nirupam Helpline to serve the underprivileged
• Antibodies Plus Antibiotics Decreases Clostridium difficile Infection Recurrence
• US FDA warns consumers about counterfeit Alli

• Mahrashtra FDA finds 24 drugs sub-standard on testing in December
• NATIONAL CONFERENCE CELLULAR AND MOLECULAR MEDICINE, Feb 4-6
• Ranbaxy enters vax space, acquires Biovel
• Bangalore Bio from June 2-4

• Path Malaria Vaccine Initiative inks pact with JHSPH & Sabin Vaccine Institute to eradicate malaria
• Hormone Therapy Ups All-Cause Mortality in Older Men With Localized Prostate Cancer
• Eisai applies for additional indication of anti-arrhythmic agent Tambocor tabs in Japan
• US FDA biopharmaceutical approval registers sharp rise in 2009
• InSightec gets approval for MRgFUS system for treatment of uterine fibroids
• Indian researchers develops nano version of a cancer drug

• Reata Pharma licenses chronic kidney disease drug bardoxolone methyl to Kyowa Hakko Kirin
• US FDA approves humanized anti-human IL-6 receptor monoclonal antibody Actemra to treat RA
• Opportunities, critical success factors for Indian biosimilar players
• Calcium, Avoiding Smoking May Limit Birth-Control Bone Loss

• DST to reformulate policy on science & technology incorporating new
• Sopherion gets US FDA fast track status for Myocet in metastatic breast cancer
• Thoracoabdominal Calcifications May Predict Cardiovascular Mortality
• Hip Fracture Risk Elevated With Pernicious Anemia: Study
• Health ministry amends rule for homoeopathic hair oils under D&C Act

------------------------------------------